PIROXICAM, EIN NEUES NICHTSTEROIDES ANTIRHEUMATIKUM. ERGEBNISSE EINER MULTIZENTRISCHEN PRUEFUNG = PIROXICAM UN NOUVEL ANTIINFLAMMATOIRE NON STEROIDE. RESULTAT D'UNE ETUDE MULTICENTRIQUEBAHR R.1980; Z. ALLG.-MED.; DEU; DA. 1980; VOL. 56; NO 3; PP. 199-205; BIBL. 6 REF.Article

Unexpected Low-Temperature Behaviour of Piroxicam MonohydrateFUCKE, Katharina; EDWARDS, Alison J; PROBERT, Michael R et al.ChemPhysChem (Print). 2013, Vol 14, Num 4, pp 675-679, issn 1439-4235, 5 p.Article

Differential permeation of piroxicam-loaded PLGA micro/nanoparticles and their in vitro enhancementSHANKARAYAN, Raju; KUMAR, Sumit; MISHRA, Prashant et al.Journal of nanoparticle research. 2013, Vol 15, Num 3, issn 1388-0764, 1496.1-1496.13Article

A pharmacokinetic study of piroxicam in childrenDIX, P; PROSSER, D. P; STREETE, P et al.Anaesthesia. 2004, Vol 59, Num 10, pp 984-987, issn 0003-2409, 4 p.Article

ACCIDENTS CUTANES PROVOQUES PAR LE PIROXICAM: A PROPOS DE TROIS OBSERVATIONSFAURE M; GOUJON C; PERROT H et al.1982; ANN. DERMATOL. VENEREOL.; ISSN 0151-9638; FRA; DA. 1982; VOL. 109; NO 3; PP. 255-258; ABS. ENG; BIBL. 3 REF.Article

Inclusion complexes of piroxicam with β-cyclodextrin derivatives in comparison with the natural β-cyclodextrin: 1st communication: Preparation and physicochemical characterizationELKHESHEN, Seham A; AHMED, Sayed M; SAMMOUR, Omima A et al.Pharmazeutische Industrie. 2002, Vol 64, Num 6, pp 612-620, issn 0031-711XArticle

Nanostructured Microspheres Produced by Supercritical Fluid Extraction of EmulsionsDELLA PORTA, Giovanna; REVERCHON, Ernesto.Biotechnology and bioengineering. 2008, Vol 100, Num 5, pp 1020-1033, issn 0006-3592, 14 p.Article

A case of generalized fixed drug eruption due to a piroxicam plasterRHO, Y. K; YOO, K. H; KIM, B. J et al.Clinical and experimental dermatology (Print). 2010, Vol 35, Num 2, pp 204-205, issn 0307-6938, 2 p.Article

Topical Treatment of Actinic Keratoses with Piroxicam 1% Gel: A Preliminary Open-Label Study Utilizing a New Clinical ScoreCAMPIONE, Elena; DILUVIO, Laura; PATERNO, Evelin Jasmine et al.American journal of clinical dermatology. 2010, Vol 11, Num 1, pp 45-50, issn 1175-0561, 6 p.Article

Spectrofluorometric determination of piroxicamDAMIANI, P. C; BEARZOTTI, M; CABEZON, M et al.Journal of pharmaceutical and biomedical analysis. 1998, Vol 17, Num 2, pp 233-236, issn 0731-7085Article

Characterization of piroxicam crystal modificationsVRECER, F; VRBINC, M; MEDEN, A et al.International journal of pharmaceutics. 2003, Vol 256, Num 1-2, pp 3-15, issn 0378-5173, 13 p.Conference Paper

KLINISCHE WIRKUNG DES ANTIRHEUMATIKEIMS PIROXICAM = ETUDE DE L'EFFET CLINIQUE DE L'ANTIINFLAMMATOIRE PIROXICAMMATHIES H; WOLFF E.1980; MUENCH. MED. WSCHR.; DEU; DA. 1980; VOL. 122; NO 3; PP. 99-102; ABS. ENG; BIBL. 10 REF.Article

Synthesis of deuterium-labelled meloxicam and piroxicamBALSSA, Frederic; BONNAIRE, Yves.Journal of labelled compounds & radiopharmaceuticals. 2007, Vol 50, Num 3-4, pp 207-210, issn 0362-4803, 4 p.Article

PHARMACOKINETICS OF PIROXICAM, A NEW NONSTEROIDAL ANTI-INFLAMMATORY AGENT, UNDER FASTING AND POSTPRANDIAL STATES IN MANISHIZAKI T; NOMURA T; ABE T et al.1979; J. PHARMACOKINET. BIOPHARMACEUT.; GBR; DA. 1979; VOL. 7; NO 4; PP. 369-381; BIBL. 19 REF.Article

REACTION AU PIROXICAM (FELDENE) A TYPE D'ECTODERMOSE EROSIVE PLURI-OFFICIELLEBERTAIL MA; CAVELIER B; CIVATTE J et al.1982; ANN. DERMATOL. VENEREOL.; ISSN 0151-9638; FRA; DA. 1982; VOL. 109; NO 3; PP. 261-262; BIBL. 1 REF.Article

PIROXICAM: A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACYBROGDEN RN; HEEL RC; SPEIGHT TM et al.1981; DRUGS (N. Y.); ISSN 0012-6667; USA; DA. 1981; VOL. 22; NO 3; PP. 165-187; BIBL. 4 P.Article

PIROXICAM (FELDEN): THEORIE UND WIRKUNGSWEISE = PIROXICAM: THEORIE ET MODE D'ACTIONWISEMAN EH.1980; AKTUEL. RHEUMATOL.; ISSN 0341-051X; DEU; DA. 1980; VOL. 5; NO 1; PP. 1-8; ABS. ENG; BIBL. 18 REF.Article

WECHSELWIRKUNG VON PIROXICAM MIT ORALEN ANTIKOAGULANTIEN = INTERACTION DU PIROXICAM ET DES ANTICOAGULANTS ORAUXJACOTOT B.1980; AKTUEL. RHEUMATOL.; ISSN 0341-051X; DEU; DA. 1980; VOL. 5; NO 1; PP. 50-52; ABS. ENGArticle

Thermal stability of piroxicam: Part 2. Kinetic study of the active substance under isothermal conditions : Current Topics of AICAT 2012TITA, Bogdan; MARIAN, Eleonora; FULIAS, Adriana et al.Journal of thermal analysis and calorimetry. 2013, Vol 112, Num 1, pp 367-374, issn 1388-6150, 8 p.Conference Paper

Topical absorption of piroxicam from organogels : in vitro and in vivo correlationsPENZES, T; BLAZSO, G; AIGNER, Z et al.International journal of pharmaceutics. 2005, Vol 298, Num 1, pp 47-54, issn 0378-5173, 8 p.Article

Spectrofluorimetric determination of 2-aminopyridine as a potential impurity in piroxicam and tenoxicam within the pharmacopoeial limitBARARY, Magda H; ABDEL-HAY, Mohamed H; SABRY, Suzy M et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 1, pp 221-226, issn 0731-7085, 6 p.Article

Spectrofluorimetric determination of piroxicam in pharmaceutical preparations and spiked human serum using micellar mediaMANZOORI, Jamshid L; AMJADI, Mohammad.Mikrochimica acta (1966. Print). 2003, Vol 143, Num 1, pp 39-44, issn 0026-3672, 6 p.Article

Inclusion of piroxicam into β-cyclodextrin by means of supercritical carbon dioxide: Thermal, spectroscopic and physicochemical studiesVAN HEES, T; EVRARD, B; PIEL, G et al.Journal de pharmacie de Belgique. 2000, Vol 55, Num 1, pp 30-31, issn 0047-2166Article

Piroxicam-β-cyclodextrin and photosensitivity reactionsVARELA, P; AMORIM, I; MASSA, A et al.Contact dermatitis. 1998, Vol 38, Num 4, issn 0105-1873, p. 229Article

Polymorphism in piroxicamSHETH, Agam R; BATES, Simon; MULLER, Francis X et al.Crystal growth & design. 2004, Vol 4, Num 6, pp 1091-1098, issn 1528-7483, 8 p.Article